ArticleBrain communications2025
Regression and machine learning approaches identify potential risk factors for glioblastoma multiforme.
Article in Brain communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Artificial Intelligence-Driven Multi-Omics Approaches in Glioblastoma.International journal of molecular sciences · 2025Review
- Nuclear and membrane-bound hormone receptors in glioblastoma: Expression, functionality, and therapeutic implications.Neuro-oncology advancesReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Glioblastoma multiforme is a lethal disease, with a 5-year survival rate of <10%. The identification of risk factors for glioblastoma multiforme is essential for the understanding of this disease and could facilitate more effective stratification of high-risk individuals. However, our current knowledge of glioblastoma multiforme risk factors is limited. Given the complexity and heterogeneity of the disease, traditional epidemiological approaches may be insufficient to study risk factors for glioblastoma multiforme. The combination of traditional approaches with machine learning models could prove effective in identifying relevant factors for glioblastoma multiforme risk. In this study, we developed glioblastoma multiformerisk models in the UK Biobank cohort using 576 glioblastoma multiforme cases and 302 602 controls. First, 369 exposures were tested with traditional regression models in a case-control study and significant associations were identified. Subsequently, significant features were filtered based on their completion rate and correlation. The selected exposures were then used to develop two machine learning models: a support vector machine and a Multi-Layer Perceptron. To address the imbalance within the subpopulation, two controls per case with full data were selected, resulting in 442 glioblastoma multiforme cases and 884 controls being analysed with the machine learning models. Relevant factors for glioblastoma multiforme risk were identified by explaining the results of the two models with Shapley Additive explanations. Traditional regression methods identified 38 significant associations between environmental exposures and glioblastoma multiforme risk under the Bonferroni threshold (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.